Everand Logo

Welcome to Everand!

  • STAT

    Opinion: It isn’t crazy to conduct an Ebola clinical trial in a war zone — it’s necessary

    The only way to evaluate possible treatments for #Ebola is to test them in a clinical trial, even though the current outbreak is spreading in what's akin to a war…
    by Jeremy Farrar Dec 04, 2018 3 minutes
    Health workers move a patient to a hospital in Butembo, Democratic Republic of the Congo, after he was cleared of having Ebola.

    The term “randomized controlled trial” conjures up images of sterile, high-tech labs with closely monitored patients hooked up to numerous machines. That’s a far cry from the reality of a brave and groundbreaking trial that began last week in the Democratic Republic of the Congo to investigate lifesaving treatments for Ebola.

    The DRC is in the midst of one of the worst Ebola outbreaks it has faced. With at least 260 people killed so far, it is

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
    When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.
    STAT1 min read
    STAT+: Element Biosciences, An Illumina Rival, On Its Genomics Ambitions — And Why It Hasn’t Gone Public
    Element Biosciences' modest growth comes at a time when some other players are struggling in a sequencer market dominated by Illumina.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
    A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

    Related Books & Audiobooks